Modification of fatty acid biosynthesis using recombinant diacylglycerol acyltransferase sequences from ryegrass (
The present invention relates to nucleic acids or nucleic acid fragments encoding amino acid sequences for fatty acid biosynthesis enzymes in plants, and the use thereof for the modification of, for example, fatty acid biosynthesis in plants. In particular, the present invention relates to nucleic acids or nucleic acid fragments encoding amino acid sequences of diacylglycerol acyltransferase enzymes.
1. A plant cell, plant, plant seed or other plant part, comprising an incorporated construct, said incorporated construct comprising a nucleic acid, wherein the nucleic acid
(1) comprises a sequence selected from the group consisting of:
(a) SEQ ID No: 10,
(b) SEQ ID No: 38,
(c) SEQ ID No: 26,
(d) SEQ ID No: 27, and
(e) a variant of SEQ ID No: 38, wherein the variant is different from SEQ ID No: 38 as a consequence of one or more nucleotide changes and wherein all of the changes result in conservative amino acid substitutions, with the proviso that the variant of SEQ ID No: 38 has at least 95% sequence identity with SEQ ID No: 38; and
encodes a diacylglycerol acyl transferase (DGAT-1); or
(2) comprises an inhibitory nucleic acid effective to reduce expression of diacylglycerol acyl transferase (DGAT-1), wherein the inhibitory nucleic acid is complementary to the full-length of a sequence listed in (a) through (e) above; and
wherein the construct alters the phenotype of the plant by altering expression levels of DGAT-1.
2. The plant cell, plant, plant seed or other plant part of claim 1 , wherein the nucleic acid comprises a sequence is selected from the group consisting of:
(a) SEQ ID No: 10;
(b) SEQ ID No: 38;
(c) a variant of SEQ ID No: 38, wherein the variant is different from SEQ ID No:38 as a consequence of one or more nucleotide changes and wherein all of the changes result in conservative amino acid substitutions, with the proviso that the variant of SEQ ID No: 38 has at least 95% sequence identity with SEQ ID No: 38;
(d) an inhibitory nucleic acid that is complementary to the full-length of SEQ ID No: 10;
(e) an inhibitory nucleic acid that is complementary to the full-length of SEQ ID No: 38; and
(f) the complement of the full length of the variant as defined in (c).
3. The plant cell, plant, plant seed or other plant part of claim 2 , wherein the nucleic acid comprises SEQ ID No: 10.
4. The plant cell, plant, plant seed or other plant part of claim 2 , wherein the nucleic acid comprises SEQ ID No: 38.
5. The plant cell, plant, plant seed or other plant part of claim 2 , wherein the nucleic acid comprises a sequence that is a variant of SEQ ID No: 38, wherein the variant is different from SEQ ID No: 38 as a consequence of one or more nucleotide changes and wherein all of the changes result in conservative amino acid substitutions, with the proviso that the variant of SEQ ID No: 38 has at least 95% sequence identity with SEQ ID No: 38.
6. The plant cell, plant, plant seed or other plant part of claim 2 , wherein the nucleic acid comprises a sequence complementary to the full-length of SEQ ID No: 10.
7. The plant cell, plant, plant seed or other plant part of claim 2 , wherein the nucleic acid comprises a sequence complementary to the full-length of SEQ ID No: 38.
8. The plant cell, plant, plant seed or other plant part of claim 2 , wherein the nucleic acid is the complement of the full-length of a variant of SEQ ID No: 38, wherein the variant is different from SEQ ID No: 38 as a consequence of one or more nucleotide changes and wherein all of the changes result in conservative amino acid substitutions, with the proviso that the variant of SEQ ID No: 38 has at least 95% sequence identity with SEQ ID No: 38.
9. The plant cell, plant, plant seed or other plant part of claim 2 , wherein the plant is a monocotyledon.
10. The plant cell, plant, plant seed or other plant part of claim 2 , wherein the plant is a dicotyledon.
11. The plant cell, plant, plant seed or other plant part of claim 1 , wherein the nucleic acid comprises a sequence is selected from the group consisting of:
(a) SEQ ID No: 26;
(b) SEQ ID No: 27;
(c) the complement of the full-length of SEQ ID No: 26; and
(d) the complement of the full-length of SEQ ID No: 27.
12. The plant cell, plant, plant seed or other plant part of claim 11 , wherein the nucleic acid comprises SEQ ID No: 26.
13. The plant cell, plant, plant seed or other plant part of claim 11 , wherein the nucleic acid comprises SEQ ID No: 27.
14. The plant cell, plant, plant seed or other plant part of claim 11 , wherein the nucleic acid comprises a sequence complementary to the full-length of SEQ ID No: 26.
15. The plant cell, plant, plant seed or other plant part of claim 11 , wherein the nucleic acid comprises a sequence complementary to the full-length of SEQ ID No: 27.
16. The plant cell, plant, plant seed or other plant part of claim 11 , wherein the plant is a monocotyledon.
17. The plant cell, plant, plant seed or other plant part of claim 11 , wherein the plant is a dicotyledon.
18. The plant cell, plant, plant seed or other plant part of claim 1 , wherein the plant is a monocotyledon.
19. The plant cell, plant, plant seed or other plant part of claim 1 , wherein the plant is a dicotyledon.
20. A method of modifying fatty acid biosynthesis in a plant, said method comprising introducing into a plant an effective amount of a nucleic acid wherein the nucleic acid
(1) comprises a sequence selected from the group consisting of:
(a) SEQ ID No: 10,
(b) SEQ ID No: 38,
(c) SEQ ID No: 26,
(d) SEQ ID No: 27, and
(e) a variant of SEQ ID No: 38, wherein the variant is different from SEQ ID No: 38 as a consequence of one or more nucleotide changes and wherein all of the changes result in conservative amino acid substitutions, with the proviso that the variant of SEQ ID No: 38 has at least 95% sequence identity with SEQ ID No: 38; and
encodes a diacylglycerol acyl transferase (DGAT-1); or
(2) comprises an inhibitory nucleic acid effective to reduce expression of diacylglycerol acyl transferase (DGAT-1), wherein the inhibitory nucleic acid is complementary to the full-length of a sequence listed in (a) through (e) above; and
wherein the nucleic acid alters the phenotype of the plant by altering expression levels of DGAT-1 to modify fatty acid biosynthesis.